TheStreet.com  Oct 6  Comment 
Note: This article discusses one or more stocks with a market cap between $350 million and $2 billion. Such small-cap stocks tend to be volatile. aNEW YORK (TheStreet) -- Imagine being jet lagged for 15 days out of every month without ever...
SeekingAlpha  Aug 7  Comment 
The following audio is from a conference call that will begin on August 07, 2014 at 10:00 AM ET. The audio will stream live while the call is active, and can be replayed upon its completion. Listen now Complete Story »
StreetInsider.com  Jun 16  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Vanda+Pharma+%28VNDA%29+Sues+Roxane+Labs+Over+Generic+Iloperidone+Oral+Tabs+ANDA/9584095.html for the full story.
Benzinga  Jun 5  Comment 
Shares of Vanda Pharmaceuticals (NASDAQ: VNDA) traded up more than 29 percent following the company's 8-K filing on Wednesday and Exhibit 99.1 presentation. History of the Drug Application On May 31, 2013, Vanda announced that it submitted...
TheStreet.com  Jun 4  Comment 
NEW YORK (TheStreet) -- Vanda Pharmaceuticals  surged Wednesday after the European Medicines Agency accepted the company's Marketing Authorization Application for Hetlioz, or tasimelteon, a medication that treats non-24-hour sleep-wake...
StreetInsider.com  Jun 4  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Vanda+Pharmaceuticals+%28VNDA%29+Gains+Ahead+of+Conference%2C+Slides+Available/9553357.html for the full story.
StreetInsider.com  Jun 3  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Vanda+Pharmaceuticals+%28VNDA%29+MAA+for+HETLIOZ+Accepted+by+EMA/9547238.html for the full story.
Capital Essence's Investment Blog- 錢途集團 » Page not found  Mar 14  Comment 
Thursday bearish breakdown suggested that short-term overbought correction off the March high of 1883 on the S&P 500 index had evolved into an intermediate-term downtrend with downside target of 1828, which we’ve determined using the trend...
SeekingAlpha  Feb 13  Comment 
Vanda Pharmaceuticals (VNDA) Q4 2013 Earnings Call February 13, 2014 10:00 am ET Executives James Patrick Kelly - Chief Financial Officer, Principal Accounting Officer, Senior Vice President, Treasurer and Secretary Mihael H....
StreetInsider.com  Feb 13  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Vanda+Pharmaceuticals%2C+Inc.+%28VNDA%29+Misses+Q4+EPS+by+3c/9164257.html for the full story.

You may also be interested in articles related to Vanda Pharmaceuticals (VNDA):


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki